Argon to pay $362.5M for Angiotech's interventional biz

Argon Medical Devices has agreed to pay $362.5 million to acquire Angiotech Pharmaceuticals' interventional products unit. The cash deal, set to be finalized by the end of next month, covers Angiotech's drainage catheters, biopsy systems and related products.

View Full Article in:

Globe and Mail (Toronto) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA